Roivant Sciences Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Roivant Sciences Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q2 2024.
  • Roivant Sciences Ltd. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $45.3M, a 12.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $45.3M -$6.32M -12.2% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $46.9M -$6.36M -11.9% Mar 31, 2024 10-Q 2024-08-09
Q4 2023 $46.9M -$7.74M -14.2% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $48.6M -$4.46M -8.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $51.6M -$7.8M -13.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $53.3M -$7.79M -12.8% Mar 31, 2023 10-K 2024-05-30
Q4 2022 $54.6M -$7.05M -11.4% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 $53.1M -$10.1M -16% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $59.4M -$5.73M -8.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $61M -$1.24M -1.98% Mar 31, 2022 10-K 2023-06-28
Q4 2021 $61.7M Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $63.2M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $65.2M Jun 30, 2021 10-Q 2021-09-21
Q1 2021 $62.3M Mar 31, 2021 10-K 2022-06-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.